During the last session, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s traded shares were 0.35 million, with the beta value of the company hitting 2.17. At the end of the trading day, the stock’s price was $3.39, reflecting an intraday gain of 4.63% or $0.15. The 52-week high for the GLMD
In the last trading session, 245,891 Vascular Biogenics Ltd. (NASDAQ:VBLT) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $2.36 changed hands at $0.07 or 0.03% during last session, the market valuation stood at $142.27 Million. VBLT’s last price
Why Vascular Biogenics Ltd (NASDAQ:VBLT) Stock Should Not Be Discarded By Investors In 2021 marketingsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketingsentinel.com Daily Mail and Mail on Sunday newspapers.
In last trading session, Sio Gene Therapies Inc. (NASDAQ:SIOX) saw 563,596 shares changing hands with its beta currently measuring 1.72. Company’s recent per share price level of $2.67 trading at $0.19 or 7.66% at ring of the bell on the day assigns it a market valuation of $156.86 Million. That closing price of SIOX’s stock is at a discount of -114.98% from its 52-week high price of $5.74 and is indicating a premium of 30.34% from its 52-week low price of $1.86. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 834.2 Million shares which gives us an average trading volume of 1.58 Million if we extend that period to 3-months.
In today’s recent session, 1,683,205 shares of the Vascular Biogenics Ltd. (NASDAQ:VBLT) have been traded, and its beta is 0.89. Most recently the company’s share price was $2.08, and it changed around $0.13 or 0.07% from the last close, which brings the market valuation of the company to $122.38 Million. VBLT at last check was trading at a discount to its 52-week high of $3.17, offering almost -52.4% off that amount. The share price’s 52-week low was $1.012, which indicates that the recent value has risen by an impressive 51.35% since then. We note from Vascular Biogenics Ltd.’s average daily trading volume that its 10-day average is 210.57 Million shares, with the 3-month average coming to 1.08 Million.